Biogen Inc. Website

Biogen Inc.

NasdaqGS-BIIB

Basic

  • Market Cap

    $31.28B

  • EV

    $37.15B

  • Shares Out

    145.6M

  • Revenue

    $9,663.1M

  • Employees

    7,570

Margins

  • Gross

    51.34%

  • EBITDA

    26.08%

  • Operating

    20.59%

  • Pre-Tax

    13.69%

  • Net

    12.07%

  • FCF

    14.37%

Returns (5Yr Avg)

  • ROA

    12.67%

  • ROTA

    34.62%

  • ROE

    25.89%

  • ROCE

    19.43%

  • ROIC

    17.81%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $285.97

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $1,074.4M

  • Net Debt

    $5,872.2M

  • Debt/Equity

    0.46

  • EBIT/Interest

    7.85

Growth (CAGR)

  • Rev 3Yr

    -8.48%

  • Rev 5Yr

    -6.89%

  • Rev 10Yr

    2.37%

  • Dil EPS 3Yr

    -25.42%

  • Dil EPS 5Yr

    -19.13%

  • Dil EPS 10Yr

    -0.05%

  • Rev Fwd 2Yr

    -1.5%

  • EBITDA Fwd 2Yr

    9.63%

  • EPS Fwd 2Yr

    8.57%

  • EPS LT Growth Est

    8.21%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Operating Revenues

11,379.8

10,692.2

10,981.7

10,173.4

9,835.6

9,663.1

Other Revenues, Total

2,998.1

2,752.4

—

—

—

—

Total Revenues

14,377.9

13,444.6

10,981.7

10,173.4

9,835.6

9,663.1

Total Revenues % Chg.

6.9%

-6.5%

-18.3%

-7.4%

-3.3%

-4.4%

Cost of Goods Sold, Total

1,955.4

5,789.8

4,606.7

4,507

4,991.7

4,701.7

Gross Profit

12,422.5

7,654.8

6,375

5,666.4

4,843.9

4,961.4

Selling General & Admin Expenses, Total

2,358.9

2,515.7

2,680.1

2,409

2,502.3

2,475.6

R&D Expenses

2,272.8

—

—

—

—

—

Amortization of Goodwill and Intangible Assets

274

255.1

252

246.3

240.6

268.7

Other Operating Expenses

—

—

241.6

232.9

7.2

-7.4

218.8

227.3

Other Operating Expenses, Total

5,147.3

3,003.7

2,939.3

2,647.9

2,961.7

2,971.6

Operating Income

7,275.2

4,651.1

3,435.7

3,018.5

1,882.2

1,989.8

Interest Expense, Total

-187.4

-213.1

-250.4

-246.6

-246.9

-253.6

Interest And Investment Income

120

42

11

89.3

276.5

213

Net Interest Expenses

-67.4

-171.1

-239.4

-157.3

29.6

-40.6

Income (Loss) On Equity Invest.

—

—

—

-79.4

5.3

34.9

2.6

—

—

Currency Exchange Gains (Loss)

-7

-10.7

-22.4

-35.5

-50.4

-49.1

Other Non Operating Income (Expenses)

-44.4

7.8

-4

-7.1

-1.7

-4.2

EBT, Excl. Unusual Items

7,077

4,482.4

3,204.8

2,821.2

1,859.7

1,895.9

Restructuring Charges

—

-1.5

—

—

-131.1

-243.3

-256

Merger & Related Restructuring Charges

—

—

—

—

—

-26.2

—

—

—

-28.4

-72.5

Gain (Loss) On Sale Of Investments

204.7

685.7

-824.9

1,228.1

-291.2

-244.1

Gain (Loss) On Sale Of Assets

—

—

—

—

-55.3

92.5

—

503.7

—

—

Asset Writedown

—

-215.9

-209.7

-629.3

-119.6

—

—

In Process R&D Expenses

—

—

—

—

-75

-18

—

—

—

Legal Settlements

—

—

—

—

—

—

—

-917

—

—

Other Unusual Items

63.7

76.9

47.5

209.1

—

—

EBT, Incl. Unusual Items

7,046.5

5,052.8

1,780.1

3,594.4

1,296.8

1,323.3

Income Tax Expense

1,158

992.3

52.5

632.8

135.3

156

Earnings From Continuing Operations

5,888.5

4,060.5

1,727.6

2,961.6

1,161.5

1,167.3

Minority Interest

—

-59.9

-171.5

85.3

-0.4

-0.7

Net Income

5,888.5

4,000.6

1,556.1

3,046.9

1,161.1

1,166.6

Net Income to Common Incl Extra Items

5,888.5

4,000.6

1,556.1

3,046.9

1,161.1

1,166.6

Net Income to Common Excl. Extra Items

5,888.5

4,000.6

1,556.1

3,046.9

1,161.1

1,166.6

Total Shares Outstanding

174.2

152.4

147

144.1

144.9

145.6

Weighted Avg. Shares Outstanding

187.1

160.9

149.1

145.3

144.7

144.9

Weighted Avg. Shares Outstanding Dil

187.4

161.3

149.6

146

145.6

145.8

EPS

31.5

24.9

10.4

21

8

8.1

EPS Diluted

31.4

24.8

10.4

20.9

8

8

EBITDA

7,739.9

5,108.3

3,923.4

3,536.9

2,377

2,519.8

Effective Tax Rate

16.4%

19.6%

2.9%

17.6%

10.4%

11.8%